Grants and Contracts per year
Personal profile
Research Interests
Phase I investigations, lung cancer, head and neck cancer, radiation-chemotherapy interactions, population studies in Appalachia.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Post Doctoral Fellow, Univ Of Kentucky
1998
Doctor of Medicine, Univ Of Kentucky
1992
Bachelor of Arts, Brown University
1985
Residency, Univ Of Virginia
1985
Fingerprint
Dive into the research topics where Susanne Arnold is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration from the last 5 years on country level. Dive into details by clicking on the dots.
-
22-HN-37-MSD (689-07): A Phase III, Randomized, Open-label Study to Evaluate Pembrolizumab as Neoadjuvant Therapy and in Combination With Standard of Care as Adjuvant Therapy for Stage III-IVA Resectable Locoregionally Advanced Head and Neck Squamous Cell
Merck Sharp & Dohme Corporation
5/11/23 → 5/10/25
Project: Research project
-
22-MULTI-53-KB-PMC : A Phase 1/1b Open-label, Multicenter Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of KIN-2787 in Participants with BRAF and/or NRAS Mutation-positive Solid Tumors, KN-8701
Kinnate Biopharma Incorporated
1/9/23 → 11/30/23
Project: Research project
-
PRiMAL: Pragmatic Randomized Clinical Trial Comparing MTB Assisted Care to Usual Care
Kolesar, J., Arnold, S., Huang, B., Hull, P., McLouth, L., Weiss, H. & Westgate, P.
9/2/22 → 11/7/23
Project: Research project
-
22-MULTI-48-AZ-PMC: D9950C00001 A Phase 1 First-in-human Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of AZD8701 Administered Intravenously as Monotherapy and in Combination with Durvalumab (MEDI4736)
AstraZeneca Pharmaceuticals LP (domestic)
7/13/22 → 6/28/23
Project: Research project
-
A Large-Scale Genome-Wide Gene-Gene Interaction Study of Lung Cancer Susceptibility in Europeans With a Trans-Ethnic Validation in Asians
Zhang, R., Shen, S., Wei, Y., Zhu, Y., Li, Y., Chen, J., Guan, J., Pan, Z., Wang, Y., Zhu, M., Xie, J., Xiao, X., Zhu, D., Li, Y., Albanes, D., Landi, M. T., Caporaso, N. E., Lam, S., Tardon, A., Chen, C., & 31 others, Aug 2022, In: Journal of Thoracic Oncology. 17, 8, p. 974-990 17 p.Research output: Contribution to journal › Article › peer-review
Open Access8 Scopus citations -
Cancer diagnosis is associated with a lower burden of dementia and less Alzheimer's-Type neuropathology
Karanth, S. D., Katsumata, Y., Nelson, P. T., Fardo, D. W., McDowell, J. K., Schmitt, F. A., Kryscio, R. J., Browning, S. R., Braithwaite, D., Arnold, S. M. & Abner, E. L., Jul 1 2022, In: Brain. 145, 7, p. 2518-2527 10 p.Research output: Contribution to journal › Article › peer-review
5 Scopus citations -
Cross-ancestry genome-wide meta-analysis of 61,047 cases and 947,237 controls identifies new susceptibility loci contributing to lung cancer
Byun, J., Han, Y., Li, Y., Xia, J., Long, E., Choi, J., Xiao, X., Zhu, M., Zhou, W., Sun, R., Bossé, Y., Song, Z., Schwartz, A., Lusk, C., Rafnar, T., Stefansson, K., Zhang, T., Zhao, W., Pettit, R. W., Liu, Y., & 65 others, Aug 2022, In: Nature Genetics. 54, 8, p. 1167-1177 11 p.Research output: Contribution to journal › Article › peer-review
6 Scopus citations -
Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD(L)-1 therapy: an open-label, multicentre, randomised, phase 2 trial
Schoenfeld, J. D., Giobbie-Hurder, A., Ranasinghe, S., Kao, K. Z., Lako, A., Tsuji, J., Liu, Y., Brennick, R. C., Gentzler, R. D., Lee, C., Hubbard, J., Arnold, S. M., Abbruzzese, J. L., Jabbour, S. K., Uboha, N. V., Stephans, K. L., Johnson, J. M., Park, H., Villaruz, L. C., Sharon, E., & 17 others, Feb 2022, In: The Lancet Oncology. 23, 2, p. 279-291 13 p.Research output: Contribution to journal › Article › peer-review
58 Scopus citations -
Exceptional Survival Among Kentucky Stage IV Non-small Cell Lung Cancer Patients: Appalachian Versus Non-Appalachian Populations
Pravosud, V., Vanderford, N. L., Huang, B., Tucker, T. C. & Arnold, S. M., Jan 1 2022, In: Journal of Rural Health. 38, 1, p. 14-27 14 p.Research output: Contribution to journal › Article › peer-review